title: Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?
authors.affiliation: a Division of Gastroenterology Hepatology, Centre of Functional Gastrointestinal & Motility Disorders , University of North Carolina Chapel Hill , Chapel Hill , NC , USA.
authors.forename: William E
authors.initials: WE
authors.lastname: Whitehead
authors.affiliation: a Division of Gastroenterology Hepatology, Centre of Functional Gastrointestinal & Motility Disorders , University of North Carolina Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Olafur S
authors.initials: OS
authors.lastname: Palsson
authors.affiliation: a Division of Gastroenterology Hepatology, Centre of Functional Gastrointestinal & Motility Disorders , University of North Carolina Chapel Hill , Chapel Hill , NC , USA.|b Gastroenterology , Sahlgrenska University Hospital , Gothenburg , Sweden.
authors.forename: Magnus
authors.initials: M
authors.lastname: Simrén
mesh_terms: D000066491:Clinical Decision-Making; D003661:Decision Support Techniques; D019317:Evidence-Based Medicine / Q000592:standards; D019983:Guideline Adherence; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D017410:Practice Guidelines as Topic / Q000592:standards*; D010818:Practice Patterns, Physicians' / Q000592:standards*; D011237:Predictive Value of Tests; D011379:Prognosis; D015203:Reproducibility of Results; D012720:Severity of Illness Index
keywords: IBS with mixed bowel habits; Irritable bowel syndrome; Rome IV criteria; clinical trial design; prevalence of IBS; validation